Below is a detailed analysis of the quarterly data for Ambuja Cements Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 9,889.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,329.00 Cr. (Dec 2024) to 9,889.00 Cr., marking an increase of 560.00 Cr..
For Expenses, as of Mar 2025, the value is 8,021.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,617.00 Cr. (Dec 2024) to 8,021.00 Cr., marking an increase of 404.00 Cr..
For Operating Profit, as of Mar 2025, the value is 1,868.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,712.00 Cr. (Dec 2024) to 1,868.00 Cr., marking an increase of 156.00 Cr..
For OPM %, as of Mar 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 18.00% (Dec 2024) to 19.00%, marking an increase of 1.00%.
For Other Income, as of Mar 2025, the value is 713.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,355.00 Cr. (Dec 2024) to 713.00 Cr., marking a decrease of 642.00 Cr..
For Interest, as of Mar 2025, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 67.00 Cr. (Dec 2024) to 14.00 Cr., marking a decrease of 53.00 Cr..
For Depreciation, as of Mar 2025, the value is 786.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 664.00 Cr. (Dec 2024) to 786.00 Cr., marking an increase of 122.00 Cr..
For Profit before tax, as of Mar 2025, the value is 1,780.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,336.00 Cr. (Dec 2024) to 1,780.00 Cr., marking a decrease of 556.00 Cr..
For Tax %, as of Mar 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from -12.00% (Dec 2024) to 28.00%, marking an increase of 40.00%.
For Net Profit, as of Mar 2025, the value is 1,282.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,620.00 Cr. (Dec 2024) to 1,282.00 Cr., marking a decrease of 1,338.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 3.88. The value appears to be declining and may need further review. It has decreased from 8.59 (Dec 2024) to 3.88, marking a decrease of 4.71.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: May 3, 2025, 3:15 pm
Metric
Dec 2013
Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023n n 15m
Mar 2024
Mar 2025
Sales
9,161
9,955
9,437
20,094
23,609
26,041
27,104
24,516
28,965
38,937
33,160
35,045
Expenses
7,492
8,022
7,895
16,913
19,751
22,030
22,507
19,511
22,755
33,815
26,760
29,074
Operating Profit
1,669
1,934
1,542
3,181
3,858
4,011
4,597
5,006
6,210
5,122
6,400
5,971
OPM %
18%
19%
16%
16%
16%
15%
17%
20%
21%
13%
19%
17%
Other Income
390
419
353
441
335
232
601
288
252
447
1,401
2,646
Interest
67
66
92
153
206
170
170
140
146
195
276
216
Depreciation
494
513
630
1,461
1,219
1,154
1,153
1,162
1,152
1,645
1,623
2,478
Profit before tax
1,498
1,774
1,173
2,008
2,768
2,919
3,875
3,992
5,164
3,729
5,901
5,922
Tax %
15%
16%
31%
29%
30%
-2%
28%
22%
28%
19%
20%
13%
Net Profit
1,278
1,487
808
1,434
1,945
2,973
2,783
3,107
3,711
3,024
4,738
5,158
EPS in Rs
8.27
9.59
5.21
5.57
7.64
10.97
10.55
11.91
14.00
13.01
16.28
16.92
Dividend Payout %
44%
46%
54%
50%
47%
14%
14%
151%
45%
19%
12%
12%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2024-2025
YoY Net Profit Growth (%)
8.86%
Change in YoY Net Profit Growth (%)
0.00%
Ambuja Cements Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2024-2025 to 2024-2025.
Growth
Compounded Sales Growth
10 Years:
13%
5 Years:
5%
3 Years:
7%
TTM:
6%
Compounded Profit Growth
10 Years:
11%
5 Years:
15%
3 Years:
13%
TTM:
23%
Stock Price CAGR
10 Years:
9%
5 Years:
23%
3 Years:
15%
1 Year:
-18%
Return on Equity
10 Years:
9%
5 Years:
10%
3 Years:
9%
Last Year:
9%
Last Updated: Unknown
No data available for the Balance Sheet data table.
After reviewing the key financial ratios for Ambuja Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 17.99. This value is within the healthy range. It has increased from 13.01 (Mar 23) to 17.99, marking an increase of 4.98.
For Diluted EPS (Rs.), as of Mar 24, the value is 16.67. This value is within the healthy range. It has increased from 12.64 (Mar 23) to 16.67, marking an increase of 4.03.
For Cash EPS (Rs.), as of Mar 24, the value is 28.84. This value is within the healthy range. It has increased from 23.37 (Mar 23) to 28.84, marking an increase of 5.47.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 231.36. It has increased from 195.18 (Mar 23) to 231.36, marking an increase of 36.18.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 231.36. It has increased from 195.18 (Mar 23) to 231.36, marking an increase of 36.18.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 150.88. It has decreased from 196.09 (Mar 23) to 150.88, marking a decrease of 45.21.
For PBDIT / Share (Rs.), as of Mar 24, the value is 34.43. This value is within the healthy range. It has increased from 29.51 (Mar 23) to 34.43, marking an increase of 4.92.
For PBIT / Share (Rs.), as of Mar 24, the value is 27.04. This value is within the healthy range. It has increased from 21.23 (Mar 23) to 27.04, marking an increase of 5.81.
For PBT / Share (Rs.), as of Mar 24, the value is 26.74. This value is within the healthy range. It has increased from 18.64 (Mar 23) to 26.74, marking an increase of 8.10.
For Net Profit / Share (Rs.), as of Mar 24, the value is 21.45. This value is within the healthy range. It has increased from 15.09 (Mar 23) to 21.45, marking an increase of 6.36.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 16.27. This value is within the healthy range. It has increased from 13.01 (Mar 23) to 16.27, marking an increase of 3.26.
For PBDIT Margin (%), as of Mar 24, the value is 22.81. This value is within the healthy range. It has increased from 15.05 (Mar 23) to 22.81, marking an increase of 7.76.
For PBIT Margin (%), as of Mar 24, the value is 17.92. This value is within the healthy range. It has increased from 10.82 (Mar 23) to 17.92, marking an increase of 7.10.
For PBT Margin (%), as of Mar 24, the value is 17.72. This value is within the healthy range. It has increased from 9.50 (Mar 23) to 17.72, marking an increase of 8.22.
For Net Profit Margin (%), as of Mar 24, the value is 14.21. This value exceeds the healthy maximum of 10. It has increased from 7.69 (Mar 23) to 14.21, marking an increase of 6.52.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.78. This value is within the healthy range. It has increased from 6.63 (Mar 23) to 10.78, marking an increase of 4.15.
For Return on Networth / Equity (%), as of Mar 24, the value is 8.62. This value is below the healthy minimum of 15. It has increased from 8.14 (Mar 23) to 8.62, marking an increase of 0.48.
For Return on Capital Employeed (%), as of Mar 24, the value is 11.17. This value is within the healthy range. It has increased from 10.48 (Mar 23) to 11.17, marking an increase of 0.69.
For Return On Assets (%), as of Mar 24, the value is 5.47. This value is within the healthy range. It has increased from 4.99 (Mar 23) to 5.47, marking an increase of 0.48.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.56. It has increased from 0.49 (Mar 23) to 0.56, marking an increase of 0.07.
For Current Ratio (X), as of Mar 24, the value is 2.05. This value is within the healthy range. It has increased from 1.67 (Mar 23) to 2.05, marking an increase of 0.38.
For Quick Ratio (X), as of Mar 24, the value is 1.75. This value is within the healthy range. It has increased from 1.39 (Mar 23) to 1.75, marking an increase of 0.36.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.61. This value is below the healthy minimum of 4. It has increased from 3.51 (Mar 23) to 3.61, marking an increase of 0.10.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 13.87. This value is below the healthy minimum of 20. It has decreased from 48.42 (Mar 23) to 13.87, marking a decrease of 34.55.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 9.54. This value is below the healthy minimum of 20. It has decreased from 29.58 (Mar 23) to 9.54, marking a decrease of 20.04.
For Earning Retention Ratio (%), as of Mar 24, the value is 86.13. This value exceeds the healthy maximum of 70. It has increased from 51.58 (Mar 23) to 86.13, marking an increase of 34.55.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 90.46. This value exceeds the healthy maximum of 70. It has increased from 70.42 (Mar 23) to 90.46, marking an increase of 20.04.
For Interest Coverage Ratio (X), as of Mar 24, the value is 27.38. This value is within the healthy range. It has decreased from 30.07 (Mar 23) to 27.38, marking a decrease of 2.69.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 17.29. This value is within the healthy range. It has decreased from 18.01 (Mar 23) to 17.29, marking a decrease of 0.72.
For Enterprise Value (Cr.), as of Mar 24, the value is 132,923.92. It has increased from 76,710.60 (Mar 23) to 132,923.92, marking an increase of 56,213.32.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.01. This value exceeds the healthy maximum of 3. It has increased from 1.97 (Mar 23) to 4.01, marking an increase of 2.04.
For EV / EBITDA (X), as of Mar 24, the value is 17.57. This value exceeds the healthy maximum of 15. It has increased from 13.09 (Mar 23) to 17.57, marking an increase of 4.48.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.06. This value exceeds the healthy maximum of 3. It has increased from 1.86 (Mar 23) to 4.06, marking an increase of 2.20.
For Retention Ratios (%), as of Mar 24, the value is 86.12. This value exceeds the healthy maximum of 70. It has increased from 51.57 (Mar 23) to 86.12, marking an increase of 34.55.
For Price / BV (X), as of Mar 24, the value is 3.25. This value exceeds the healthy maximum of 3. It has increased from 2.29 (Mar 23) to 3.25, marking an increase of 0.96.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.06. This value exceeds the healthy maximum of 3. It has increased from 1.86 (Mar 23) to 4.06, marking an increase of 2.20.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Ambuja Cements Ltd as of June 13, 2025 is: 491.33
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 13, 2025, Ambuja Cements Ltd is Overvalued by 9.35% compared to the current share price 542.00
Intrinsic Value of Ambuja Cements Ltd as of June 13, 2025 is: 527.07
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 13, 2025, Ambuja Cements Ltd is Overvalued by 2.75% compared to the current share price 542.00
Last 5 Year EPS CAGR: 7.27%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambuja Cements Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 8.62% (Industry Average ROE: 14.62%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 32.3 (Industry average Stock P/E: 58.21)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Ambuja Cements Ltd. is a Public Limited Listed company incorporated on 20/10/1981 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L26942GJ1981PLC004717 and registration number is 004717. Currently Company is involved in the business activities of Manufacture of clinkers and cement. Company's Total Operating Revenue is Rs. 19453.59 Cr. and Equity Capital is Rs. 492.62 Cr. for the Year ended 31/03/2025.
INDUSTRY
ADDRESS
CONTACT
Cement
Adani Corporate House, Shantigram, Near Vaishnavdevi Circle, Ahmedabad Gujarat 382421
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Ambuja Cements Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
